🇺🇸 dexmedetomidine hydrochloride for injection in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Altered State Of Consciousness — 1 report (10%)
  2. Anuria — 1 report (10%)
  3. Blindness — 1 report (10%)
  4. Blindness Cortical — 1 report (10%)
  5. Cardiogenic Shock — 1 report (10%)
  6. Cerebral Infarction — 1 report (10%)
  7. Circulatory Collapse — 1 report (10%)
  8. Colour Blindness — 1 report (10%)
  9. Condition Aggravated — 1 report (10%)
  10. Csf Pressure Increased — 1 report (10%)

Source database →

dexmedetomidine hydrochloride for injection in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is dexmedetomidine hydrochloride for injection approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for dexmedetomidine hydrochloride for injection in United States?

Peking University First Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.